161 related articles for article (PubMed ID: 10999044)
1. Influence of antiestrogens on the invasiveness and laminin attachment of breast cancer cells.
Rajah TT; Pento JT
Cancer Invest; 1999; 17(1):10-8. PubMed ID: 10999044
[TBL] [Abstract][Full Text] [Related]
2. The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells.
Tong GM; Rajah TT; Zang XP; Pento JT
Anticancer Res; 2002; 22(1A):103-6. PubMed ID: 12017270
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens.
Thompson EW; Reich R; Shima TB; Albini A; Graf J; Martin GR; Dickson RB; Lippman ME
Cancer Res; 1988 Dec; 48(23):6764-8. PubMed ID: 2846159
[TBL] [Abstract][Full Text] [Related]
4. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
[TBL] [Abstract][Full Text] [Related]
5. Antiestrogens are pro-apoptotic in normal human breast epithelial cells.
Somaï S; Chaouat M; Jacob D; Perrot JY; Rostène W; Forgez P; Gompel A
Int J Cancer; 2003 Jul; 105(5):607-12. PubMed ID: 12740907
[TBL] [Abstract][Full Text] [Related]
6. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
[TBL] [Abstract][Full Text] [Related]
7. Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain.
Varma H; Conrad SE
Oncogene; 2000 Sep; 19(41):4746-53. PubMed ID: 11032025
[TBL] [Abstract][Full Text] [Related]
8. Phytosterols reduce in vitro metastatic ability of MDA-MB-231 human breast cancer cells.
Awad AB; Williams H; Fink CS
Nutr Cancer; 2001; 40(2):157-64. PubMed ID: 11962251
[TBL] [Abstract][Full Text] [Related]
9. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
Treeck O; Haldar C; Ortmann O
Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061
[TBL] [Abstract][Full Text] [Related]
11. Antitumor mechanism of action of a cyclopropyl antiestrogen (compound 7b) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Cancer Chemother Pharmacol; 1996; 38(3):238-44. PubMed ID: 8646798
[TBL] [Abstract][Full Text] [Related]
12. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
Müller V; Jensen EV; Knabbe C
Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
[TBL] [Abstract][Full Text] [Related]
13. Influence of cyclopropyl antiestrogens on the cell cycle kinetics of MCF-7 human breast cancer cells.
Jain PT; Pento JT; Magarian RA
Anticancer Res; 1995; 15(6B):2529-32. PubMed ID: 8669818
[TBL] [Abstract][Full Text] [Related]
14. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
Thompson EW; Katz D; Shima TB; Wakeling AE; Lippman ME; Dickson RB
Cancer Res; 1989 Dec; 49(24 Pt 1):6929-34. PubMed ID: 2582435
[TBL] [Abstract][Full Text] [Related]
15. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
[TBL] [Abstract][Full Text] [Related]
16. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells.
Abbas Abidi SM; Howard EW; Dmytryk JJ; Pento JT
Clin Exp Metastasis; 1997 Jul; 15(4):432-9. PubMed ID: 9219732
[TBL] [Abstract][Full Text] [Related]
17. Differences in morphology and cytoskeleton of MCF-7 and MX-1 cells after therapy with OH-tamoxifen and the pure estrogen antagonist ZM 182780. An immunofluorescence and scanning electron microscopic study.
Ehlers EM; Schubert C
Ann Anat; 1999 May; 181(3):231-6. PubMed ID: 10363104
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiestrogens on EGF-mediated movement of human breast cancer cells.
Tong GM; Rajah TT; Zang XP; Bahr SJ; Pento JT
Pharmacology; 2007; 79(2):93-6. PubMed ID: 17164579
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.
Joffroy CM; Buck MB; Stope MB; Popp SL; Pfizenmaier K; Knabbe C
Cancer Res; 2010 Feb; 70(4):1314-22. PubMed ID: 20145137
[TBL] [Abstract][Full Text] [Related]
20. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
